Moreover, Chu et al. reported that ALOX12 expression is downregulated in many cancer types, including cervical carcinoma, head and neck carcinoma, esophageal carcinoma, and acute myeloid leukemia. This evidence concerns the gene ALOX12 and head and neck carcinoma.